Literature DB >> 32035186

Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of Meynert.

Milan Nemy1, Nira Cedres2, Michel J Grothe3, J-Sebastian Muehlboeck4, Olof Lindberg4, Zuzana Nedelska5, Olga Stepankova6, Lenka Vyslouzilova6, Maria Eriksdotter7, José Barroso8, Stefan Teipel9, Eric Westman10, Daniel Ferreira11.   

Abstract

The integrity of the cholinergic system plays a central role in cognitive decline both in normal aging and neurological disorders including Alzheimer's disease and vascular cognitive impairment. Most of the previous neuroimaging research has focused on the integrity of the cholinergic basal forebrain, or its sub-region the nucleus basalis of Meynert (NBM). Tractography using diffusion tensor imaging data may enable modelling of the NBM white matter projections. We investigated the contribution of NBM volume, NBM white matter projections, small vessel disease (SVD), and age to performance in attention and memory in 262 cognitively normal individuals (39-77 years of age, 53% female). We developed a multimodal MRI pipeline for NBM segmentation and diffusion-based tracking of NBM white matter projections, and computed white matter hypointensities (WM-hypo) as a marker of SVD. We successfully tracked pathways that closely resemble the spatial layout of the cholinergic system as seen in previous post-mortem and DTI tractography studies. We found that high WM-hypo load was associated with older age, male sex, and lower performance in attention and memory. A high WM-hypo load was also associated with lower integrity of the cholinergic system above and beyond the effect of age. In a multivariate model, age and integrity of NBM white matter projections were stronger contributors than WM-hypo load and NBM volume to performance in attention and memory. We conclude that the integrity of NBM white matter projections plays a fundamental role in cognitive aging. This and other modern neuroimaging methods offer new opportunities to re-evaluate the cholinergic hypothesis of cognitive aging.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Basal forebrain; Cholinergic system; Cognition; Magnetic resonance imaging; Normal aging; Small vessel disease

Mesh:

Year:  2020        PMID: 32035186     DOI: 10.1016/j.neuroimage.2020.116607

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  18 in total

1.  Older adults' episodic memory is related to a neurophysiological marker of brain cholinergic activity.

Authors:  Patrick S R Davidson; Galit Karpov; Lauriane Giguère; Alex W Castro; François Tremblay
Journal:  Exp Brain Res       Date:  2022-07-30       Impact factor: 2.064

2.  Association of Cerebrovascular and Alzheimer Disease Biomarkers With Cholinergic White Matter Degeneration in Cognitively Unimpaired Individuals.

Authors:  Nira Cedres; Daniel Ferreira; Milan Nemy; Alejandra Machado; Joana B Pereira; Sara Shams; Lars-Olof Wahlund; Anna Zettergren; Olga Stepankova; Lenka Vyslouzilova; Maria Eriksdotter; Stefan Teipel; Michel J Grothe; Kaj Blennow; Henrik Zetterberg; Michael Schöll; Silke Kern; Ingmar Skoog; Eric Westman
Journal:  Neurology       Date:  2022-08-02       Impact factor: 11.800

3.  Three-Dimensional Spatial Analyses of Cholinergic Neuronal Distributions Across The Mouse Septum, Nucleus Basalis, Globus Pallidus, Nucleus Accumbens, and Caudate-Putamen.

Authors:  Andres Carrasco; Dorothy E Oorschot; Paolo Barzaghi; Jeffery R Wickens
Journal:  Neuroinformatics       Date:  2022-07-06

4.  New Developments in Cholinergic Imaging in Alzheimer and Lewy Body Disorders.

Authors:  Chesney E Craig; Nicola J Ray; Martijn L T M Müller; Nicolaas I Bohnen
Journal:  Curr Behav Neurosci Rep       Date:  2020-10-09

5.  Circulating Angiotensin-(1-7) Is Reduced in Alzheimer's Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study.

Authors:  Victor Teatini Ribeiro; Thiago Macedo E Cordeiro; Roberta da Silva Filha; Lucas Giandoni Perez; Paulo Caramelli; Antônio Lúcio Teixeira; Leonardo Cruz de Souza; Ana Cristina Simões E Silva
Journal:  Front Neurosci       Date:  2021-04-06       Impact factor: 4.677

6.  Cortical connectivity of the nucleus basalis of Meynert in Parkinson's disease and Lewy body dementias.

Authors:  Ashwini Oswal; James Gratwicke; Harith Akram; Marjan Jahanshahi; Laszlo Zaborszky; Peter Brown; Marwan Hariz; Ludvic Zrinzo; Tom Foltynie; Vladimir Litvak
Journal:  Brain       Date:  2021-04-12       Impact factor: 13.501

7.  Cortical Networks Underpinning Compensation of Verbal Fluency in Normal Aging.

Authors:  Lissett Gonzalez-Burgos; Joana B Pereira; Rosaleena Mohanty; José Barroso; Eric Westman; Daniel Ferreira
Journal:  Cereb Cortex       Date:  2021-07-05       Impact factor: 5.357

8.  Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies.

Authors:  Daniel Ferreira; Zuzana Nedelska; Jonathan Graff-Radford; Scott A Przybelski; Timothy G Lesnick; Christopher G Schwarz; Hugo Botha; Matthew L Senjem; Julie A Fields; David S Knopman; Rodolfo Savica; Tanis J Ferman; Neill R Graff-Radford; Val J Lowe; Clifford R Jack; Ronald C Petersen; Afina W Lemstra; Marleen van de Beek; Frederik Barkhof; Frederic Blanc; Paulo Loureiro de Sousa; Nathalie Philippi; Benjamin Cretin; Catherine Demuynck; Jakub Hort; Ketil Oppedal; Bradley F Boeve; Dag Aarsland; Eric Westman; Kejal Kantarci
Journal:  Neurobiol Aging       Date:  2021-05-14       Impact factor: 5.133

9.  The cholinergic system in subtypes of Alzheimer's disease: an in vivo longitudinal MRI study.

Authors:  Alejandra Machado; Daniel Ferreira; Michel J Grothe; Helga Eyjolfsdottir; Per M Almqvist; Lena Cavallin; Göran Lind; Bengt Linderoth; Åke Seiger; Stefan Teipel; Lars U Wahlberg; Lars-Olof Wahlund; Eric Westman; Maria Eriksdotter
Journal:  Alzheimers Res Ther       Date:  2020-05-06       Impact factor: 6.982

10.  Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease.

Authors:  Nicola J Ray; Lynn Rochester; Joanna Wilson; Alison J Yarnall; Chesney E Craig; Brook Galna; Sue Lord; Rosie Morris; Rachael A Lawson; Lisa Alcock; Gordon W Duncan; Tien K Khoo; John T O'Brien; David J Burn; John-Paul Taylor
Journal:  Mov Disord       Date:  2020-12-31       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.